看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -7.0x - -7.7x | -7.4x |
| Selected Fwd P/E Multiple | -5.3x - -5.8x | -5.6x |
| Fair Value | kr11.22 - kr12.40 | kr11.81 |
| Upside | 12.2% - 24.0% | 18.1% |
| Benchmarks | - | Full Ticker |
| Demant A/S | - | CPSE:DEMANT |
| Ambu A/S | - | CPSE:AMBUB |
| Coloplast A/S | - | CPSE:COLOB |
| BioMaxima S.A. | - | WSE:BMX |
| CVRx, Inc. | - | NasdaqGS:CVRX |
| ViroGates A/S | - | CPSE:VIRO |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| DEMANT | AMBU B | COLO B | BMX | CVRX | VIRO | |||
| CPSE:DEMANT | CPSE:AMBUB | CPSE:COLOB | WSE:BMX | NasdaqGS:CVRX | CPSE:VIRO | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 14.6% | -5.8% | 5.5% | NM- | NM- | NM- | ||
| 3Y CAGR | 2.4% | -1.6% | 1.5% | -62.6% | NM- | NM- | ||
| Latest Twelve Months | 2.5% | 0.8% | -8.5% | 142.1% | 3.9% | -6.1% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 10.1% | 4.8% | 21.0% | 9.5% | -192.7% | -233.7% | ||
| Prior Fiscal Year | 13.1% | 3.5% | 19.5% | 1.3% | -104.8% | -173.1% | ||
| Latest Fiscal Year | 12.9% | 4.4% | 18.7% | 1.0% | -116.9% | -200.9% | ||
| Latest Twelve Months | 12.9% | 6.3% | 16.3% | 1.5% | -95.6% | -198.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 13.5x | 25.2x | 19.0x | 13.8x | -3.0x | NA | ||
| Price / LTM Sales | 2.4x | 4.1x | 4.9x | 1.0x | 3.6x | 11.4x | ||
| LTM P/E Ratio | 18.6x | 65.2x | 30.1x | 62.4x | -3.8x | -5.7x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -3.8x | 30.1x | 65.2x | |||||
| Historical LTM P/E Ratio | -25.2x | -11.3x | -3.7x | |||||
| Selected P/E Multiple | -7.0x | -7.4x | -7.7x | |||||
| (x) LTM Net Income | (14) | (14) | (14) | |||||
| (=) Equity Value | 95 | 100 | 105 | |||||
| (/) Shares Outstanding | 7.7 | 7.7 | 7.7 | |||||
| Implied Value Range | 12.24 | 12.88 | 13.52 | |||||
| FX Rate: DKK/DKK | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 12.24 | 12.88 | 13.52 | 10.00 | ||||
| Upside / (Downside) | 22.4% | 28.8% | 35.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DEMANT | AMBU B | COLO B | BMX | CVRX | VIRO | |
| Value of Common Equity | 53,978 | 24,375 | 136,316 | 55 | 196 | 77 | |
| (/) Shares Outstanding | 213.0 | 266.4 | 225.2 | 4.2 | 26.2 | 7.7 | |
| Implied Stock Price | 253.40 | 91.50 | 605.40 | 13.15 | 7.51 | 10.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 253.40 | 91.50 | 605.40 | 13.15 | 7.51 | 10.00 | |
| Trading Currency | DKK | DKK | DKK | PLN | USD | DKK | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |